ANG Lifesciences Statements
54
ANG Lifesciences Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
563.85
100
366.37
65
197.48
35
—
0
86.401
15.3
222.62
39.5
-25.142
-4.5
-63.532
-11.3
1.583
0.3
-104.44
-18.5
-8.664
-1.5
-95.777
-17
-7.27
13.191
897.24
100
584.76
64.7
312.49
35.3
—
0
107.12
14.9
274.54
37
37.947
-1.7
-46.04
-6.9
5.399
0.7
-2.694
-7.9
2.959
-0.9
-5.652
-7
-0.374
12.709
863.63
100
667.64
93.1
195.99
6.9
—
0
112.06
14.8
322.78
40.7
-126.79
-33.7
-51.22
-4.2
94.712
23.4
-83.295
-14.5
-19.45
-2.8
-63.844
-11.7
-4.907
13.024
1 335.28
100
838.25
61.5
497.03
38.5
—
0
127.65
11
322.43
25.9
174.6
12.6
-67.567
-5.5
2.514
0.3
109.55
7.3
48.322
2.9
61.222
4.4
5.392
11.446
1 449.88
100
995.72
70.4
454.16
29.6
—
0
113.39
6
314.99
19
139.17
10.6
-59.201
-4.1
7.253
0.6
87.223
7.1
21.975
1.6
65.248
5.5
5.051
12.703
2 093.36
100
1 284.22
61.3
809.14
38.7
—
0
98.439
4.7
333.22
15.9
475.92
22.7
-30.07
-1.4
1.761
0.08
447.61
21.4
118.94
5.7
328.67
15.7
25.392
12.944
682.51
100
428.81
62.8
253.71
37.2
—
0
76.368
11.2
211.64
31
42.068
6.2
-15.432
-2.3
1.275
0.2
27.911
4.1
12.657
1.9
15.255
2.2
1.177
12.964
861.28
100
610.8
70.9
250.48
29.1
—
0
60.389
7
167.06
19.4
83.421
9.7
-14.225
-1.7
4.284
0.5
73.479
8.5
18.457
2.1
55.022
6.4
4.248
12.952
682.01
100
456.79
67
225.22
33
—
0
52.593
7.7
169.97
24.9
55.247
8.1
-13.788
-2.02
2.94
0.4
44.399
6.5
11.883
1.7
32.516
4.8
3.135
10.373
1 259.93
100
907.56
73.8
352.37
26.2
—
0
59.114
4.6
239.94
17.1
112.43
9.1
-28.162
-2.5
2.751
0.2
87.017
6.8
29.179
1.9
57.838
4.9
5.579
10.367